Clin2
NCT07381803Likely a fitRecruiting

Fexofenadine for heart attack recovery

Zhejiang University

Treatments studied

Part of Heart & circulation clinical trials.

This trial tests if the allergy medicine fexofenadine can improve recovery after a heart attack. You may qualify if you had a specific type of heart attack (STEMI) within the last week.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 3
Enrollment
2,804 people
Ages
18 years and older
Study type
Interventional

Who can take part

  • You are 18 years or older.
  • You had a type of heart attack called STEMI within the last 7 days.
  • You understand the risks and benefits and agree to take part.
  • You have not had bypass surgery or long-term use of similar allergy drugs.
  • You do not have severe kidney or liver problems, active infection, or cancer.
  • You are not pregnant or breastfeeding.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT06548204Recruiting· Phase 2
Antihistamine after a heart attack

This trial tests whether taking an antihistamine medicine called fexofenadine hydrochloride can help people recover better after a heart attack. It is a randomized study, so some participants will receive the medicine and others will receive a placebo (a pill with no active ingredients).

Hangzhou, Zhejiang
NCT07153744Not yet recruiting· Phase 4
Chinese medicine for recent heart attack

This trial adds a Chinese medicine (Shexiang Baoxin Pill) to standard care for people having a heart attack, to see if it improves recovery when taken alongside the usual artery-opening procedure. It may help speed up heart recovery and reduce further damage.

Shanghai
NCT06699407Not yet recruiting· Phase 4
Herbal treatment for heart recovery after a heart attack

This trial tests a Chinese herbal medicine called Qishenyiqi to see if it helps the heart recover and remodel (repair its shape) after a heart attack. It is for people whose heart is still weak (pumping less than 40%) and who have heart failure symptoms.

Jinan, Shandong
NCT06785298Recruiting· Phase 2/Phase 3
Fexofenadine as add-on treatment for Parkinson's disease

This trial tests whether adding fexofenadine, a common allergy medicine, to your current Parkinson's treatment can help improve symptoms. It's for people aged 50 or older who are already on dopamine replacement therapy.

Tanta
NCT06961136Recruiting
Herbal medicine for recovery after heart bypass surgery

This trial tests if a traditional Chinese herbal formula (Fuzheng Yangxin Prescription) can help people recover faster after coronary artery bypass surgery. It is for people who have a specific pattern of symptoms (called Qi-Yin deficiency) after their operation.

Beijing, Beijing Municipality
NCT07776288Not yet recruiting· Phase 2
Antioxidant therapy after a first heart attack

This trial tests whether giving a combination of antioxidant vitamins (supplements) during emergency treatment for a first heart attack can reduce heart muscle damage and improve recovery. You might be eligible if you are having an emergency angioplasty for a recent heart attack.

Santiago, Santiago Metropolitan

Hear when a new Zhejiang University trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.